Fox Chase Cancer Center Welcomes Dr. Saba Shaikh

Shaikh, MD, an assistant professor in the Department of Hematology/Oncology

PHILADELPHIA (June 30, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Saba Shaikh, MD, as an assistant professor in the Department of Hematology/Oncology, where she will be caring for gastrointestinal and breast cancer patients.

Shaikh earned her undergraduate degree in neuroscience from the University of Texas at Dallas. She received her medical degree in 2016 from the Baylor College of Medicine, where she also completed a certification in medical ethics, and went on to complete her internal medicine residency at Northwestern University’s McGaw Medical Center.

She then moved on to a hematology/oncology fellowship at the University of Pittsburgh Medical Center, where she also served as chief fellow in her final year.

Shaikh’s research interests lie in the development of novel therapeutic strategies for patients with solid tumors who have become resistant to immune checkpoint inhibitors. She has authored multiple peer-reviewed articles and belongs to several professional societies, including the American Society of Clinical Oncology, the American Society of Hematology, and the Society for Immunotherapy of Cancer.

Throughout her academic career, Shaikh taught at the University of Texas at Dallas, Baylor College of Medicine, Northwestern University Feinberg School of Medicine, and the University of Pittsburgh Medical Center.

She has received multiple teaching awards, including the Resident Teaching Award at the Feinberg School of Medicine three years in a row.

Shaikh will begin her tenure at Fox Chase on July 1, 2022.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427